Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22557| Title: | Real-world appropriateness of imaging severity thresholds in interstitial lung disease clinical trials. | Austin Authors: | Ryerson, Christopher J;Goh, Nicole S L | Affiliation: | Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, BC, Canada Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada. Institute for Breathing and Sleep Respiratory and Sleep Medicine University of Melbourne, Melbourne, VIC, Australia |
Issue Date: | Feb-2020 | Publication information: | The Lancet. Respiratory Medicine 2020; 8(2): e7 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/22557 | DOI: | 10.1016/S2213-2600(20)30004-7 | ORCID: | 0000-0003-2065-4346 |
Journal: | The Lancet. Respiratory Medicine | PubMed URL: | 32035069 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.